Gastroenterology

Diverticular Disease

~15 min read8 sections
⭐ High-yield🎯 Drill Gastroenterology
Contents (8)

Diverticular disease comprises a spectrum of disorders characterized by the presence of diverticula—outpouchings of the colon mucosa and submucosa through the muscular wall—with or without associated inflammation. The disease ranges from asymptomatic diverticulosis (diverticula without symptoms) to symptomatic uncomplicated diverticulosis and acute diverticulitis (inflammation of diverticula with clinical symptoms). Diverticulosis affects approximately 5-10% of the population in Western countries by age 40, increasing to 50% by age 60, with left-sided (sigmoid) predominance in Western populations and right-sided (cecal/ascending) predominance in Asian populations. Diverticulitis accounts for 2.4% of acute abdominal admissions and has become increasingly common in younger age groups over the past two decades. Understanding the pathophysiology and natural history of diverticular disease is critical for appropriate risk stratification, patient counseling regarding complications, and evidence-based management decisions.

The development and complications of diverticular disease involve complex interplay between structural colonic anatomy, intraluminal pressure dynamics, muscular dysfunction, and mucosal inflammatory response:

  • Anatomic predisposition and penetrating vessels: Diverticula form at specific weak points in the colonic wall where blood vessels (specifically the vasa recta) penetrate the circular muscle layer to supply the mucosa. These natural defects in the muscle wall create sites of herniation. In the sigmoid colon, the taeniae coli (three longitudinal muscle bands) create a triangular area adjacent to the medial blood vessel entry points where the muscular wall is thinnest. Unlike small intestine diverticula that form between mesenteric and antimesenteric borders, colonic diverticula consistently occur along the mesenteric taenia, reinforcing the vascular basis of herniation. With aging, progressive weakening of the mucosa and submucosa, combined with elastin and collagen degradation, increases susceptibility to herniation at these predisposed sites.
  • Altered motility and elevated intraluminal pressure: Elevated segmental colonic pressure is a fundamental mechanism driving diverticula formation. In susceptible individuals, the sigmoid colon generates higher baseline pressures due to increased muscular contraction and reduced luminal diameter (Laplace's law: pressure = 2 × wall tension/radius). Abnormal motor patterns include increased frequency and amplitude of non-propagated contractions, reduced transit time in the sigmoid, and paradoxical pressure increases during defecation. These pressure abnormalities may reflect underlying smooth muscle dysfunction with altered expression of ion channels, gap junctions (Connexin 43), and neurotransmitter signaling (reduced nitric oxide synthase expression, abnormal acetylcholine signaling). Low dietary fiber intake directly contributes to elevated pressures by reducing stool bulk, increasing segmentation, and promoting increased muscular contraction to propel smaller, denser fecal material. The chronic elevation of intraluminal pressure gradually herniates the mucosa and submucosa through the muscular defects, forming progressively larger diverticula.
  • Mucosal and visceral inflammation: Diverticulitis develops when obstruction or bacterial colonization of a diverticulum triggers acute mucosal inflammation. Impacted fecal material, undigested food particles, or altered bacterial flora within the diverticulum create a closed-loop obstruction analogous to appendicitis. Increased intraluminal pressure within the trapped diverticulum compromises the microvasculature, leading to mucosal ischemia and translocation of luminal bacteria across the epithelial barrier. This breach triggers innate immune activation with upregulation of toll-like receptors (TLRs), particularly TLR2 and TLR4, promoting release of pro-inflammatory cytokines (TNF-α, IL-6, IL-8) and chemokine-mediated neutrophil recruitment. Dysbiosis of the colonic microbiota—characterized by reduced bacterial diversity, decreased Faecalibacterium prausnitzii, and enrichment of pathogenic gram-negative organisms—exacerbates the inflammatory response. Visceral hypersensitivity and altered tight junction function (reduced claudins and occludin) facilitate bacterial translocation. Polymorphonuclear leukocyte infiltration of the diverticular wall causes acute transmural inflammation. In uncomplicated diverticulitis, inflammation remains confined to the diverticulum and immediately adjacent tissue. Progressive inflammation and pressure necrosis can lead to microperforation with localized abscess formation or frank macroperforation with free peritonitis.
  • Chronic inflammation and fibrosis: Repeated episodes of diverticulitis trigger chronic changes characterized by fibrosis, stricture formation, and persistent visceral pain. Activation of fibroblasts and myofibroblasts by TGF-β and other cytokines leads to excessive collagen deposition in the submucosa and muscularis propria. This results in loss of normal colonic compliance, wall thickening, and potential stenosis. Persistent low-grade inflammation between symptomatic episodes may perpetuate pain signaling through neuropathic mechanisms (upregulation of substance P and CGRP in enteric neurons). Altered barrier function with increased intestinal permeability (measured by zonula occludens-1 dysfunction) persists even during symptom remission.
  • Genetic and epigenetic factors: Twin studies and family aggregation data suggest a heritable component, with estimated heritability of 40-50%. Genome-wide association studies (GWAS) have identified associations with variants in genes affecting colonic motility, immune signaling, and angiogenesis, though no single Mendelian locus explains diverticulosis. Epigenetic changes, particularly altered DNA methylation patterns in inflammatory response genes, have been demonstrated in diverticulitis tissues. Age-related telomere shortening and cellular senescence may explain the strong age dependence of disease.

  • Low dietary fiber intake: Western diet characterized by refined carbohydrates and insufficient fiber (<15 g/day) is the primary modifiable risk factor for diverticulosis development. Fiber reduces intraluminal pressure through increased stool bulk and improved colonic transit. Fermentable fiber enhances butyrate production by beneficial bacteria (Faecalibacterium prausnitzii), maintaining intestinal barrier integrity and immune homeostasis. Conversely, low-fiber diet promotes dysbiosis, reduced short-chain fatty acid production, increased fecal stasis in the sigmoid colon, and elevated segmental pressures. The incidence of symptomatic diverticulosis has increased proportionately with decline in dietary fiber consumption over the past 50 years.
  • Advanced age: Age is the strongest non-modifiable risk factor, with exponential increase in prevalence with each decade beyond age 40. Collagen composition changes with aging, characterized by increased advanced glycation end products (AGEs) and cross-linking, reducing elasticity and tissue compliance. Progressive smooth muscle changes include increased connective tissue infiltration, altered expression of smooth muscle myosin heavy chains, and accumulation of lipofuscin within smooth muscle cells. Autonomic nervous system changes with aging affect colonic motility regulation. By age 80, prevalence of diverticulosis approaches 70-80% in Western populations.
  • Obesity and metabolic factors: Increased visceral adiposity is associated with higher risk of symptomatic diverticulitis, likely through multiple mechanisms including chronic systemic inflammation (elevated TNF-α, IL-6), altered adipokine signaling, and increased intraluminal colonic pressure. Metabolic syndrome components (hypertension, dyslipidemia, insulin resistance) independently increase diverticulitis risk. Elevated fasting glucose and HbA1c predict complications. Visceral obesity promotes dysbiosis and altered fecal microbiota composition predisposing to diverticulitis.
  • Physical inactivity and constipation: Sedentary lifestyle is associated with increased diverticulitis risk; regular physical activity reduces risk by 37% in cohort studies. Constipation with straining increases intraluminal pressure and promotes dysbiosis. Prolonged colonic transit time facilitates bacterial overgrowth within diverticula. Conversely, appropriate bowel regularity and soft stool consistency reduce diverticulitis risk.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs): Regular NSAID use increases diverticulitis risk by 1.5-2 fold through multiple mechanisms: direct mucosal irritation and barrier dysfunction, altered colonic microbiota, increased intestinal permeability, and altered immune regulation. The effect is dose- and duration-dependent, with highest risk in chronic users. Acetaminophen and corticosteroids do not confer increased risk.
  • Smoking: Active smoking increases acute diverticulitis risk 2-3 fold, possibly through impaired mucosal healing, altered immune function, reduced colonic blood flow, and promotion of dysbiosis. Former smokers retain elevated risk for several years after cessation. The effect may be stronger in younger patients.
  • Alcohol consumption: Heavy alcohol use (>2 drinks daily) increases diverticulitis risk, while moderate consumption is neutral or protective. Alcohol impairs intestinal barrier function, reduces mucus layer integrity, promotes dysbiosis, and enhances bacterial translocation. Acetaldehyde metabolism generates oxidative stress.
  • Genetic susceptibility and familial disease: Approximately 50% of patients with diverticulitis report a family history of diverticular disease. Specific genetic polymorphisms in IL-6, TNF-α promoter regions, and genes affecting colonic motility increase susceptibility. Familial clustering suggests both shared genetic and environmental (dietary) factors. However, no inherited diverticular disease syndromes exist comparable to familial adenomatous polyposis.
  • Secondary diverticulosis: Colonic diverticula can develop secondary to other conditions including Marfan syndrome, Ehlers-Danlos syndrome (types with vascular complications), and Carcinoid syndrome (from excessive serotonin causing fibrosis). Behçet's disease causes intestinal inflammation predisposing to diverticulitis. Polycystic kidney disease (PKD1 mutations) is associated with colonic diverticula, though mechanism is unclear.

The clinical presentation of diverticular disease spans an asymptomatic state to life-threatening acute peritonitis, with highly variable symptomatology:

  • Asymptomatic diverticulosis: Approximately 80% of individuals with colonic diverticula remain asymptomatic and are diagnosed incidentally on colonoscopy or imaging performed for other indications. These patients have excellent long-term prognosis with low lifetime risk of diverticulitis (only 4-15% lifetime risk, revised downward from earlier estimates of 20%). Microbiological and imaging studies confirm diverticula are present but without mucosal inflammation, fecal impaction, or systemic inflammation.
  • Symptomatic uncomplicated diverticulosis (painful diverticulosis): 10-25% of patients with diverticula experience chronic or recurrent abdominal symptoms without acute inflammation or imaging evidence of diverticulitis. Left lower quadrant (LLQ) abdominal pain is the cardinal symptom, typically mild to moderate in severity, often crampy or dull, and may be constant or intermittent. Pain may worsen with eating and improve with defecation (visceral pain pattern). Associated symptoms include bloating, alterations in bowel habits (constipation alternating with diarrhea), flatulence, and mucus in stool. The pathophysiology involves visceral hypersensitivity, altered motility, and low-grade mucosal inflammation below the threshold for acute diverticulitis. Symptoms may persist for weeks to months or occur intermittently. Distinguishing painful diverticulosis from irritable bowel syndrome (IBS) can be challenging, as symptoms overlap significantly; however, diverticulosis shows evidence of diverticula on imaging while IBS does not.
  • Acute diverticulitis: Acute-onset severe LLQ pain is the hallmark presentation, typically developing over hours to 1-2 days. Pain is usually constant, sharp or cramping, and localized to the left lower abdomen (reflecting sigmoid colon inflammation); however, right lower quadrant pain occurs in Asian populations with right-sided diverticulosis and can cause diagnostic confusion with appendicitis. Associated symptoms include fever (present in 50-60% of uncomplicated cases, more common in complicated disease), nausea and vomiting (20-40%, more common with peritoneal irritation or obstruction), and change in bowel habits (constipation or diarrhea). Some patients report antecedent crampy pain and bowel dysfunction preceding the acute episode. On physical examination, focal LLQ tenderness is nearly universal, with degree of tenderness correlating with inflammation severity. Rebound tenderness and guarding indicate peritoneal irritation or perforation; their presence correlates with complicated disease. Palpable mass or fullness in the LLQ may be appreciated if abscess or phlegmon has formed. Fever (temperature >38.5°C) is more common in complicated diverticulitis. Tachycardia reflects systemic inflammation and pain. Abdominal rigidity and acute abdomen presentation suggest perforation with peritonitis.
  • Complicated diverticulitis with abscess formation: Some patients present with clinical features suggesting localized suppurative complication. Persistent fever and chills despite initial treatment suggest abscess. LLQ mass, fullness, or fluctuance may be palpable if large enough. Sepsis with hemodynamic instability can occur, particularly in immunocompromised patients. Patients may report urinary symptoms (dysuria, frequency) if abscess compresses bladder or rectal symptoms (tenesmus, mucus discharge) if inflammation extends into rectum or has perforated into rectum.
  • Perforation with free peritonitis: This represents a surgical emergency. Acute severe diffuse abdominal pain with sudden worsening indicates rupture. Patients appear acutely toxic with marked fever (>39°C), tachycardia (heart rate >110), hypotension, and altered mental status. Rigid abdomen with generalized rebound and guarding indicates peritoneal soiling. Nausea and vomiting are prominent. Leukocytosis with left shift and elevated lactate/procalcitonin reflect severe systemic inflammation. Without emergent surgical intervention, rapid progression to septic shock and death occurs.
  • Fistulization: Diverticulitis eroding into adjacent organs creates internal fistulas with characteristic presentations. Colovesical fistula (most common, 60%) causes pneumaturia (passage of gas in urine), fecaluria (fecal material in urine), recurrent urinary tract infections, and dysuria without bacteriuria; patients describe "passing stool through urinary stream." Colovaginal fistula causes vaginal discharge with fecal odor. Colocutaneous fistula presents with drainage from abdominal wall. Diagnosis requires imaging (CT with IV contrast) or cystography; treatment is surgical.
  • Stenosis and obstruction: Chronic recurrent diverticulitis leads to stricture formation in the sigmoid colon through fibrosis of the muscular and mucosal layers. Patients develop progressive constipation, abdominal distention, colicky pain, and potentially complete colonic obstruction. The degree of stenosis can range from asymptomatic narrowing to complete obstruction. Obstructing lesions require careful colonoscopic evaluation to exclude malignancy, as diverticular strictures are difficult to differentiate from malignancy on imaging alone.

Diagnosis of diverticular disease requires integration of clinical presentation, laboratory findings, and imaging studies:

  • Clinical assessment and diagnostic criteria: Acute diverticulitis diagnosis requires presence of symptoms (abdominal pain or tenderness, typically LLQ) and imaging findings consistent with inflammation, or in the absence of imaging, clinical findings with supporting laboratory abnormalities. The modified Hinchey classification (described below) provides anatomic staging. Symptomatic uncomplicated diverticulosis is diagnosed when patients report chronic or recurrent LLQ pain in the setting of known diverticula without acute inflammation on imaging. Detailed history should assess risk factors (fiber intake, NSAID use, smoking), previous diverticulitis episodes, and current symptom severity (affecting quality of life vs. incidental). Assess for immunosuppression (HIV, transplant, chronic corticosteroids) as this affects management urgency.
  • Laboratory findings: White blood cell count (WBC) elevation (>10,500/μL) is present in 55-80% of acute diverticulitis; left shift with immature bands correlates with disease severity. C-reactive protein (CRP) elevation reflects systemic inflammation and is more sensitive than WBC, present in >90% of cases. Procalcitonin >0.5 ng/mL indicates systemic infection and helps differentiate infection from sterile inflammation. Elevated lactate (>2 mmol/L) suggests tissue hypoperfusion and correlates with severe disease and complications. Mild transaminitis may occur with inflammation. Complete metabolic panel may show dehydration (elevated BUN/creatinine ratio, elevated sodium). Normal WBC and

Initial stabilization (complicated or toxic-appearing disease)

  • Resuscitation first: large-bore IV access, isotonic crystalloid, bowel rest, and early broad-spectrum IV antibiotics with source control for suspected perforation or septic shock, consistent with Surviving Sepsis Campaign principles. Serial abdominal exams, NPO status, and urgent surgical consultation are mandatory when peritonitis is present.

Uncomplicated acute diverticulitis

  • Selective (not automatic) antibiotics: both the AGA (2015) and ACG (2021) suggest that antibiotics can be omitted in immunocompetent, non-toxic outpatients with mild CT-confirmed uncomplicated diverticulitis — the disease is largely inflammatory rather than purely infectious. Supportive care is clear liquids advanced as tolerated plus analgesia.
  • When antibiotics are used, cover gram-negative aerobes and anaerobes: a beta-lactam/beta-lactamase inhibitor (amoxicillin-clavulanate) orally, or a fluoroquinolone (ciprofloxacin) plus metronidazole if beta-lactam intolerant.
  • Inpatient therapy for inability to tolerate PO, significant comorbidity, immunosuppression, or failure of outpatient care: IV ceftriaxone plus metronidazole, or piperacillin-tazobactam for sicker patients.

Escalation and definitive management

  • Abscess: small pericolic collections (roughly <3–4 cm) are typically treated with antibiotics alone; larger or accessible collections, and those with persistent fever or leukocytosis after 48–72 hours, undergo CT-guided percutaneous drainage before any elective resection (ASCRS 2020).
  • Hinchey III/IV (purulent or feculent peritonitis): emergency laparotomy with sigmoid resection — Hartmann procedure (end colostomy) or resection with primary anastomosis and diverting ileostomy in stable patients.
  • Elective sigmoid colectomy: ASCRS emphasizes an individualized decision based on severity, persistent symptoms, fistula, stricture, and immunosuppression — not an arbitrary episode count.
  • Interval colonoscopy ~6–8 weeks after resolution is suggested after complicated diverticulitis, and after uncomplicated disease if there is no recent high-quality colonoscopy, to exclude occult colorectal cancer (ACG 2021).

Avoid

  • Colonoscopy or barium enema during the acute attack — perforation risk.
  • NSAIDs (recurrence and perforation risk).
  • Mesalamine is not recommended for prevention of recurrent diverticulitis (ACG 2021, conditional recommendation against); evidence is insufficient to support rifaximin or probiotics for this indication.
  • Dietary restriction of nuts, seeds, or popcorn — disproven.

Complications of the disease

  • Abscess (Hinchey I–II): contained microperforation walls off into a pericolic or pelvic collection. Signalled by persistent fever and leukocytosis despite 48–72 hours of appropriate antibiotics, or a palpable tender LLQ mass; confirmed on CT. Small collections (roughly <3–4 cm) are usually managed with antibiotics alone, while larger or accessible collections — and any collection with persistent fever or leukocytosis after 48–72 hours — warrant CT-guided percutaneous drainage (ASCRS 2020).
  • Free perforation with purulent or feculent peritonitis (Hinchey III–IV): surgical emergency. Rigid abdomen, absent bowel sounds, hypotension, rising lactate; upright film or CT shows free intraperitoneal air. Mortality rises steeply with delay to source control.
  • Diverticular hemorrhage: erosion of the vasa recta stretched over the diverticular dome produces painless, brisk hematochezia — the mechanism is arterial, not inflammatory, which is why bleeding and diverticulitis rarely coexist. Massive bleeding with hemodynamic instability is an emergency requiring resuscitation, then colonoscopic hemostasis or CT angiography with embolization.
  • Fistula: chronic transmural inflammation erodes into an adjacent hollow viscus. Colovesical fistula is most common and announces itself as pneumaturia, fecaluria, and recurrent polymicrobial UTI; colovaginal fistula causes feculent vaginal discharge.
  • Stricture and large-bowel obstruction: fibrotic healing narrows the sigmoid; progressive constipation, distention, and obstipation follow. Must be distinguished from annular constricting carcinoma — endoscopic biopsy is required.
  • Pylephlebitis and hepatic abscess: septic thrombophlebitis of the portal vein from mesenteric venous seeding; suspect with fever, jaundice, and bacteremia (often Bacteroides).

Complications of treatment

  • Antibiotic-associated Clostridioides difficile colitis: watery diarrhea and leukocytosis after fluoroquinolone or beta-lactam exposure — a key reason antibiotics are now used selectively.
  • Fluoroquinolone toxicity: tendinopathy, QT prolongation, and aortic aneurysm/dissection risk (FDA warnings).
  • Surgical morbidity: anastomotic leak (fever, ileus, peritonitis in the first postoperative week — emergency), stoma complications, and low anterior resection–type bowel dysfunction.

  • **Colonic diverticula are false (pseudo)diverticula**: mucosa and submucosa herniate through the muscularis where the vasa recta pierce the wall. The classic contrast is Meckel diverticulum, a true diverticulum containing all layers.
  • Best next step for suspected acute diverticulitis is CT of the abdomen and pelvis with IV contrast — it confirms the diagnosis, stages it (modified Hinchey), and detects abscess or free air. Colonoscopy and barium enema in the acute setting are the classic wrong answers (perforation risk); colonoscopy comes 6–8 weeks later — after complicated disease, or after uncomplicated disease if there is no recent high-quality exam — to exclude malignancy (ACG 2021).
  • Diverticulitis is left-sided; diverticular bleeding is disproportionately right-sided and painless. Diverticulosis is the most common cause of brisk lower GI bleeding in adults — angiodysplasia is the usual distractor (slower, oozing, associated with aortic stenosis and von Willebrand dysfunction, Heyde syndrome).
  • Pneumaturia + fecaluria + recurrent UTI = colovesical fistula until proven otherwise; get CT, and remember treatment is surgical.
  • Antibiotics are no longer automatic for mild uncomplicated disease in immunocompetent outpatients (AGA/ACG). When used, the regimen must cover anaerobes — metronidazole-containing or amoxicillin-clavulanate.
  • Elective colectomy is individualized, not episode-count driven (ASCRS). "Resect after two attacks" is outdated exam bait; immunosuppression, fistula, and stricture are the real drivers.
  • Nuts, seeds, corn, and popcorn do not cause diverticulitis — advising avoidance is a distractor. Counsel high-fiber diet, exercise, weight loss, smoking cessation, and NSAID avoidance.
  • Right-sided diverticulitis in an Asian patient mimics appendicitis; CT distinguishes them.
  • Free air + rigid abdomen = perforated diverticulitis with peritonitis (Hinchey III or IV): resuscitate, IV antibiotics, urgent laparotomy (Hartmann procedure) — not percutaneous drainage. Purulent = III, feculent = IV, distinguished at operation.

Related topics

← Back to library